Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ONCO is expected to report earnings to rise 10.53% to -20 cents per share on March 07
Q4'23
Est.
$-0.21
Q3'23
Est.
$-0.19
Q2'23
Missed
by $0.06
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.05
The last earnings report on November 09 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 571.04K shares outstanding, the current market capitalization sits at 1.15M.